Angelika Hanschmann, MS

Doctor
Merz Therapeutics GmbH, Germany

Poster(s):

• 300 Section - Goal Attainment and Ambulation With Increasing Doses of IncobotulinumtoxinA: A Post Hoc Analysis of the TOWER Study
  Tuesday, May 19, 2026

  6:00 PM - 7:30 PM PT

• 400 Section - IncobotulinumtoxinA for the Treatment of Lower Limb Spasticity in Children and Adolescents with Cerebral Palsy: Evaluation of Lower Limb IncobotulinumtoxinA Efficacy (ELLIE)
  Tuesday, May 19, 2026

  6:00 PM - 7:30 PM PT